cancers Article Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation Mélissa Prat 1,†, Marie Salon 1,2,†, Thibault Allain 1, Olivier Dubreuil 3, ...